New weight loss injection begins human testing
Disease control
Terminated
This is the first study in people to test the safety of a new drug called HCR-188, given as an injection. Researchers will give increasing doses to small groups of overweight or obese volunteers to see how their bodies react and if the drug is well-tolerated. The main goal is to …
Phase: EARLY_PHASE1 • Sponsor: Helicore Biopharma, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC